enow.com Web Search

  1. Ads

    related to: secondary progressive ms treatment 2023 reviews youtube

Search results

  1. Results from the WOW.Com Content Network
  2. Siponimod - Wikipedia

    en.wikipedia.org/wiki/Siponimod

    Siponimod is indicated for the treatment of secondary progressive multiple sclerosis, which is the progressive neurological decline of multiple sclerosis that happens independent of acute relapses. [1] In active secondary progressive multiple sclerosis, siponimod decreases the risk of disability and multiple sclerosis relapses. [1]

  3. Multiple sclerosis drug pipeline - Wikipedia

    en.wikipedia.org/wiki/Multiple_sclerosis_drug...

    The appropriate pathway to put forward masitinib through the regulatory agencies, for the treatment of progressive forms of multiple sclerosis, is under study [34] evobrutinib is a selective oral Bruton's tyrosine kinase (BTK) inhibitor that has been shown to inhibit B-cell activation both in vitro and in vivo.

  4. Glatiramer acetate - Wikipedia

    en.wikipedia.org/wiki/Glatiramer_acetate

    Glatiramer acetate (also known as Copolymer 1, Cop-1), sold under the brand name Copaxone among others, is an immunomodulator medication used to treat multiple sclerosis. [1] [2] Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability.

  5. A Baffling Rise In MS Cases Has Doctors Seeking Answers To ...

    www.aol.com/baffling-rise-ms-cases-doctors...

    Here's a quick primer on multiple sclerosis. MS is an autoimmune disease that attacks myelin—the fatty insulation that surrounds the nerves in the spinal cord and brain. In severe cases, MS can ...

  6. MIS416 - Wikipedia

    en.wikipedia.org/wiki/MIS416

    MIS416 is a microparticle derived from the cytoskeleton of P. acnes, [5] a species of bacteria present on the skin of most adults that causes acne. [6]MIS416 was originally developed as a vaccine adjuvant, a component of vaccines that helps to activate an immune response against the vaccine target.

  7. Research in multiple sclerosis - Wikipedia

    en.wikipedia.org/wiki/Research_in_multiple_sclerosis

    Simvastatin has shown brain atrophy reduction in secondary progressive MS. [54] Masitinib, a tyrosine kinase inhibitor, is in late-stage testing for the treatment of patients with secondary and primary progressive MS (PPMS). It is a twice-daily oral medication that targets mast cells and inhibits several biochemical processes.14

  1. Ads

    related to: secondary progressive ms treatment 2023 reviews youtube